Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-04-29 Option Award | 2024-04-30 12:20 pm | 2024-04-29 2025-04-29 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward CEO | 50,000 | $0 | 1,785,000 (Direct) | View |
2024-04-25 Exercise | 2024-04-26 09:00 am | 2023-04-25 2024-04-25 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward CEO | 137,752 | $0 | 2,913,704 (Direct) | View |
2024-04-19 Option Award | 2024-04-22 11:08 am | 2024-04-19 2025-04-19 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 25,000 | $0 | 1,835,000 (Direct) | View |
2024-04-11 Option Award | 2024-04-15 3:45 pm | 2024-04-11 2025-04-11 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 20,000 | $0 | 1,810,000 (Direct) | View |
2024-04-06 Exercise | 2024-04-09 4:31 pm | 2023-04-06 2024-04-06 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 172,190 | $0 | 2,930,952 (Direct) | View |
2024-03-26 Option Award | 2024-03-26 4:49 pm | 2024-03-26 2025-03-26 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 400,000 | $400,000 | 1,915,000 (Direct) | View |
2024-03-21 Option Award | 2024-03-22 10:58 am | 2024-03-21 2025-03-21 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 25,000 | $25,000 | 1,515,000 (Direct) | View |
2024-03-17 Exercise | 2024-03-18 5:29 pm | 2023-03-17 2024-03-17 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 172,190 | $0 | 2,583,762 (Direct) | View |
2024-02-28 Disposition | 2024-02-29 09:22 am | 2021-08-16 2023-08-16 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Raines Heather CFO | 50,000 | $50,000 | 125,000 (Direct) | View |
2024-02-27 Option Award | 2024-02-28 3:16 pm | 2024-02-27 2025-02-27 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 180,000 | $180,000 | 1,615,000 (Direct) | View |
2024-02-27 Exercise | 2024-02-28 2:12 pm | 2023-02-27 2024-02-27 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 137,744 | $0 | 2,481,572 (Direct) | View |
2024-02-17 Exercise | 2024-02-20 11:12 am | 2023-02-17 2024-02-17 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 172,180 | $0 | 2,543,828 (Direct) | View |
2024-02-15 Option Award | 2024-02-16 5:54 pm | 2024-02-15 2025-02-15 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 75,000 | $75,000 | 1,660,000 (Direct) | View |
2024-02-02 Disposition | 2024-02-06 3:16 pm | 2021-08-16 2023-08-16 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Raines Heather CFO | 25,000 | $25,000 | 175,000 (Direct) | View |
2024-01-30 Option Award | 2024-02-01 5:29 pm | 2024-01-30 2025-01-30 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 135,000 | $135,000 | 1,585,000 (Direct) | View |
2024-01-26 Exercise | 2024-01-29 4:21 pm | 2023-01-26 2024-01-26 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 172,180 | $0 | 2,411,648 (Direct) | View |
2024-01-12 Exercise | 2024-01-12 2:55 pm | 2023-01-12 2024-01-12 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 172,180 | $0 | 2,489,468 (Direct) | View |
2023-12-28 Option Award | 2023-12-29 4:56 pm | 2023-12-28 2024-12-28 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 100,000 | $100,000 | 1,675,000 (Direct) | View |
2023-12-22 Exercise | 2023-12-22 11:39 am | 2022-12-22 2023-12-22 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 34,440 | $0 | 2,451,728 (Direct) | View |
2023-12-19 Exercise | 2023-12-20 4:07 pm | 2022-12-19 2023-12-19 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 137,760 | $0 | 2,467,288 (Direct) | View |
2023-12-02 Exercise | 2023-12-04 12:49 pm | 2022-12-02 2023-12-02 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 206,628 | $0 | 2,529,528 (Direct) | View |
2023-11-29 Option Award | 2023-11-30 6:51 pm | 2023-11-29 2024-11-29 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 50,000 | $50,000 | 1,850,000 (Direct) | View |
2023-11-15 Exercise | 2023-11-15 5:23 pm | 2022-11-15 2023-11-15 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 34,440 | $0 | 2,572,920 (Direct) | View |
2023-11-08 Exercise | 2023-11-13 09:00 am | 2022-11-08 2023-11-08 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 137,744 | $0 | 2,588,480 (Direct) | View |
2023-11-01 Exercise | 2023-11-01 09:30 am | 2022-11-01 2023-11-01 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 48,216 | $0 | 2,650,736 (Direct) | View |
2023-10-27 Exercise | 2023-10-27 5:55 pm | 2022-10-27 2023-10-27 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 10,332 | $0 | 2,672,520 (Direct) | View |
2023-10-14 Exercise | 2023-10-19 5:16 pm | 2022-10-14 2023-10-14 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 68,888 | $0 | 3,367,988 (Direct) | View |
2023-09-01 Exercise | 2023-10-05 12:04 pm | 2022-09-01 2023-09-01 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 392,598 | $0 | 6,148,111 (Direct) | View |
2022-09-01 Option Award | 2023-10-05 12:04 pm | 2022-09-01 2023-09-01 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 100,000 | $100,000 | 6,148,111 (Direct) | View |
2023-08-11 Option Award | 2023-08-14 7:07 pm | 2023-08-11 2024-08-11 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Morris Jeffrey Allen 10% Owner | 700,000 | $0 | 22,740,331 (Direct) | View |
2023-08-03 Option Award | 2023-08-04 12:48 pm | 2023-08-03 2024-08-03 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 75,000 | $75,000 | 2,202,500 (Direct) | View |
2023-07-28 Exercise | 2023-07-28 3:36 pm | 2022-07-27 2023-07-28 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 109,393 | $0 | 663,891 (Direct) | View |
2023-07-24 Exercise | 2023-07-26 7:54 pm | 2022-07-15 2023-07-24 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 218,739 | $0 | 610,565 (Direct) | View |
2023-07-20 Option Award | 2023-07-24 7:34 pm | 2023-07-20 2024-07-20 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 125,000 | $125,000 | 2,127,500 (Direct) | View |
2023-06-30 Option Award | 2023-07-05 10:41 am | 2023-06-30 2024-06-30 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 125,000 | $125,000 | 2,002,500 (Direct) | View |
2023-06-15 Option Award | 2023-06-16 6:40 pm | 2023-06-15 2024-06-15 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 125,000 | $125,000 | 1,877,500 (Direct) | View |
2023-05-26 Option Award | 2023-05-30 3:48 pm | 2023-05-26 2024-05-26 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 50,000 | $50,000 | 1,752,500 (Direct) | View |
2023-05-12 Option Award | 2023-05-15 2:04 pm | 2023-05-12 2024-05-12 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 200,000 | $200,000 | 1,702,500 (Direct) | View |
2023-05-08 Conversion | 2023-05-09 4:50 pm | N/A N/A | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Morris Jeffrey Allen 10% Owner | 188,757 | $2.862 | 22,495,747 (Direct) | View |
2023-04-25 Option Award | 2023-04-26 6:40 pm | 2023-04-25 2024-04-25 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 100,000 | $100,000 | 1,502,500 (Direct) | View |
2023-04-06 Option Award | 2023-04-10 1:55 pm | 2023-04-06 2024-04-06 | PROVECTUS BIOPHARMACEUTICALS INC. | PVCT | Pershing Edward Director | 125,000 | $125,000 | 1,402,500 (Direct) | View |